Scientific article
English

CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study

Published inAlzheimer's and Dementia, vol. 11, no. 11, p. 1306-1315
Publication date2015
Abstract

The aim of this study was to test the diagnostic value of cerebrospinal fluid (CSF) beta-amyloid (Aβ1-42), phosphorylated tau, and total tau (tau) to discriminate Alzheimer's disease (AD) dementia from other forms of dementia.

Keywords
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease/cerebrospinal fluid/diagnosis
  • Amyloid beta-Peptides/cerebrospinal fluid
  • Biomarkers/cerebrospinal fluid
  • Diagnosis, Differential
  • Female
  • Humans
  • Internationality
  • Male
  • Middle Aged
  • Peptide Fragments/cerebrospinal fluid
  • Phosphorylation
  • Sensitivity and Specificity
  • Spinal Puncture
  • tau Proteins/cerebrospinal fluid
Affiliation entities Not a UNIGE publication
Citation (ISO format)
EWERS, Michael et al. CSF biomarkers for the differential diagnosis of Alzheimer’s disease: A large-scale international multicenter study. In: Alzheimer’s and Dementia, 2015, vol. 11, n° 11, p. 1306–1315. doi: 10.1016/j.jalz.2014.12.006
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1552-5260
422views
0downloads

Technical informations

Creation08/06/2018 10:15:00
First validation08/06/2018 10:15:00
Update27/06/2025 11:45:31
Status update27/06/2025 11:45:31
Last indexation27/06/2025 11:47:34
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack